Kerry J. Lavender

867 total citations
25 papers, 522 citations indexed

About

Kerry J. Lavender is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Kerry J. Lavender has authored 25 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 10 papers in Virology and 9 papers in Infectious Diseases. Recurrent topics in Kerry J. Lavender's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (11 papers) and HIV Research and Treatment (10 papers). Kerry J. Lavender is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (11 papers) and HIV Research and Treatment (10 papers). Kerry J. Lavender collaborates with scholars based in United States, Canada and Germany. Kerry J. Lavender's co-authors include Kim J. Hasenkrug, Ronald J. Messer, Brent Race, Kevin P. Kane, Ulf Dittmer, Katie Phillips, Barton F. Haynes, Andrew J. McMichael, Persephone Borrow and Dana Scott and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Kerry J. Lavender

24 papers receiving 516 citations

Peers

Countries citing papers authored by Kerry J. Lavender

Since Specialization

Citations

This map shows the geographic impact of Kerry J. Lavender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry J. Lavender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry J. Lavender more than expected).

Fields of papers citing papers by Kerry J. Lavender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry J. Lavender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry J. Lavender. The network helps show where Kerry J. Lavender may publish in the future.

Co-authorship network of co-authors of Kerry J. Lavender

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry J. Lavender. A scholar is included among the top collaborators of Kerry J. Lavender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry J. Lavender. Kerry J. Lavender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2 2023 ·Nature Communications ·Magen E. Francis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rachelle Buchanan, Kerry J. Lavender, (unknown), Matthew B. Rogers, J. Lew, Volker Gerdts, Darryl Falzarano, Danuta M. Skowronski, Calvin Sjaarda, Alyson A. Kelvin	2
2	Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles 2023 ·PLoS Pathogens ·(unknown), Wibke Bayer, (unknown), (unknown), (unknown), Kathrin Sutter, Kirsten Bruderek, (unknown), Kerry J. Lavender, Mario L. Santiago, (unknown), Carina Elsner, Stefan Eßer, Sven Brandau, Matthias Gunzer, Ulf Dittmer	1
3	SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model 2022 ·Viruses ·(unknown), J. Lew, (unknown), Anna Radomska, (unknown), (unknown), Steven Machtaler, Darryl Falzarano, Kerry J. Lavender	4
4	Inducing Long-Term HIV-1 Latency in the TKO-BLT Mouse Model 2022 ·Methods in molecular biology ·(unknown), Kerry J. Lavender	3
5	Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis 2020 ·PLoS Pathogens ·Kejun Guo, (unknown), Jon Kibbie, (unknown), Stephanie M. Dillon, (unknown), Emily Cooper, Kerry J. Lavender, Kim J. Hasenkrug, Kathrin Sutter, Ulf Dittmer, Miranda Kroehl, Katerina Kechris, Cara C. Wilson, Mario L. Santiago	16
6	Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir 2019 ·Scientific Reports ·Kathrin Sutter, Kerry J. Lavender, Ronald J. Messer, Marek Widera, Katie Williams, Brent Race, Kim J. Hasenkrug, Ulf Dittmer	14
7	An advanced BLT-humanized mouse model for extended HIV-1 cure studies 2017 ·AIDS ·Kerry J. Lavender, Craig S. Pace, Kathrin Sutter, Ronald J. Messer, (unknown), Nathan W. Cummins, Sekar Natesampillai, Jim Zheng, Joshua Goldsmith, Marek Widera, Erik Van Dis, Katie Phillips, Brent Race, Ulf Dittmer, George Kukolj, Kim J. Hasenkrug	54
8	Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment 2016 ·The Journal of Infectious Diseases ·Jessica R. Spengler, Kerry J. Lavender, Cynthia Martellaro, Aaron Carmody, Andreas Kurth, James Keck, Greg Saturday, Dana Scott, Stuart T. Nichol, Kim J. Hasenkrug, Christina F. Spiropoulou, Heinz Feldmann, Joseph Prescott	22
9	No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts 2015 ·Virology ·Erik Van Dis, (unknown), Kerry J. Lavender, Ronald J. Messer, Oliver T. Keppler, Jens Verheyen, Ulf Dittmer, Kim J. Hasenkrug	11
10	Mice of the resistant H-2b haplotype mount broad CD4+ T cell responses against 9 distinct Friend virus epitopes 2014 ·Virology ·Ronald J. Messer, Kerry J. Lavender, Kim J. Hasenkrug	17
11	Production of bone marrow, liver, thymus (BLT) humanized mice on the C57BL/6 Rag2−/−γc−/−CD47−/− background 2014 ·Journal of Immunological Methods ·Kerry J. Lavender, Ronald J. Messer, Brent Race, Kim J. Hasenkrug	26
12	BLT-humanized C57BL/6 Rag2−/−γc−/−CD47−/− mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection 2013 ·Blood ·Kerry J. Lavender, Wendy W. Pang, Ronald J. Messer, (unknown), Brent Race, Katie Phillips, Dana Scott, Karin E. Peterson, Charles K. F. Chan, Ulf Dittmer, Timothy Dudek, Todd M. Allen, Irving L. Weissman, Kim J. Hasenkrug	99
13	Elevation of Intact and Proteolytic Fragments of Acute Phase Proteins Constitutes the Earliest Systemic Antiviral Response in HIV-1 Infection 2010 ·PLoS Pathogens ·Holger Kramer, Kerry J. Lavender, Qin Li, Andrea Stacey, Michael K. P. Liu, Katalin di Gleria, Alison Simmons, (unknown), Barton F. Haynes, Andrew J. McMichael, Persephone Borrow, Benedikt M. Kessler	77
14	Loss of DNAM‐1 contributes to CD8⁺ T‐cell exhaustion in chronic HIV‐1 infection 2010 ·European Journal of Immunology ·Marina Cella, Rachel M. Presti, William Vermi, Kerry J. Lavender, Emma L. Turnbull, Christina Ochsenbauer‐Jambor, John C. Kappes, Guido Ferrari, (unknown), Ian Williams, Andrew J. McMichael, Barton F. Haynes, Persephone Borrow, Marco Colonna	44
15	Determining Ligand Specificity of Ly49 Receptors 2009 ·Methods in molecular biology ·Kerry J. Lavender, Kevin P. Kane	0
16	Distinctive Interactions at Multiple Site 2 Subsites by Allele-Specific Rat and Mouse Ly49 Determine Functional Binding and Class I MHC Specificity 2007 ·The Journal of Immunology ·Kerry J. Lavender, (unknown), Kevin P. Kane	4
17	Cross-Species Dependence of Ly49 Recognition on the Supertype Defining B-Pocket of a Class I MHC Molecule 2006 ·The Journal of Immunology ·Kerry J. Lavender, Kevin P. Kane	7
18	The Rat RT1-A1c MHC Molecule Is a Xenogeneic Ligand Recognized by the Mouse Activating Ly-49W and Inhibitory Ly-49G Receptors 2004 ·The Journal of Immunology ·Kerry J. Lavender, J. Brian, (unknown), Kevin P. Kane	6
19	Ly-49 Receptors and Their Functions 2004 ·Critical Reviews in Immunology ·J. Brian, Kevin P. Kane, Kerry J. Lavender	21
20	Allelic Variation in the Ectodomain of the Inhibitory Ly-49G2 Receptor Alters Its Specificity for Allogeneic and Xenogeneic Ligands 2002 ·The Journal of Immunology ·(unknown), Kerry J. Lavender, (unknown), Bart Hazes, Kevin P. Kane	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact